✦ LIBER ✦

Comparison of Viscoelastometric Assays to Traditional Activated Clotting Time for Assessing Heparin Activity in Whole Blood

✍ Scribed by Chapman, M.P.; Moore, E.E.; Chin, T.L.; Ghasabyan, A.; Ramos, C.R.; Stringham, J.R.; Banerjee, A.

Book ID: 123248585
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 59 KB
Volume: 179
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2012.10.324

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of activated clotting times t

Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty

✍ Helft, Gérard ;Choktron, Sylvie ;Beygui, Farzyn ;Le Feuvre, Claude ;Elalamy, Ism 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

The aim of this study was to compare the activated clotting time (ACT) obtained with the Hemochron device and the Heparin Management Test (HMT) on a new automated whole-blood coagulometer, the Thrombolytic Assessment System, in patients undergoing angioplasty. Fifty patients undergoing balloon angio

Comparison of activated partial thrombop

Comparison of activated partial thromboplastin time to activated clotting time for adequacy of heparin anticoagulation just before percutaneous transluminal coronary angioplasty

✍ Howard P. Grill; Joel E. Spero; Jerome E. Granato 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 258 KB

In vitro heparinization of canine whole

In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time

✍ Lisbeth R. Jessen; Bo Wiinberg; Asger L. Jensen; Mads Kjelgaard-Hansen; Kate H. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

Sensitivity of whole blood clotting time

Sensitivity of whole blood clotting time and activated partial thromboplastin time for factor IX: relevance to gene therapy and determination of post-transfusion elimination time of canine factor IX in hemophilia B dogs

✍ T. C. NICHOLS; H. W. G. FRANCK; C. T. FRANCK; N. de FRIESS; R. A. RAYMER; E. P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Comparison between siliconized evacuated

Comparison between siliconized evacuated glass and plastic blood collection tubes for prothrombin time and activated partial thromboplastin time assay in normal patients, patients on oral anticoagulant therapy and patients with unfractioned heparin therapy

✍ G. D’ANGELO; C. VILLA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Development and application of a biomark

Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood

✍ Maya Arai; Sadhana Jain; Amy A Weaver; Andrew A Hill; Yongjing Guo; Andrea G Bre 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 820 KB